April 7 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* KAZIA THERAPEUTICS LTD - PAXALISIB SHOWS POSITIVE OVERALL SURVIVAL SIGNAL IN PHASE II GLIOBLASTOMA STUDY
* KAZIA THERAPEUTICS LTD - LONGEST-TREATED PATIENT REMAINS PROGRESSION-FREE 19 MONTHS AFTER DIAGNOSIS IN PHASE II GLIOBASTOMA STUDY